ENTITY

United Biopharma (6471 TT)

Health Care • Taiwan

United BioPharma Inc is equipped with a complete monoclonal antibody drug development technology platform that allows the company to develop, manufacture, and sell innovative monoclonal antibodies and biological similarity antibodies solutions.

Refresh

No filings found

We’ll display filings we find for United Biopharma here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00